. Author manuscript; available in PMC: 2016 Apr 19.

Published in final edited form as: Biol Blood Marrow Transplant. 2015 Apr 4;21(7):1237–1245. doi: 10.1016/j.bbmt.2015.03.011

Table 1. Patient Characteristics.

	ATG 5.1	ATG 7.5
N	19	22
Male	12	14
Median age (range)	57 (44-69)	57 (40-68)
Donor
Matched related donor	9	10
Unrelated donor	10	12
HLA Mismatch	2	2
Stem cell source
Bone marrow	2	2
Peripheral blood	17	20
Diagnosis and prior therapy
MM	5	4
NHL	7	8
AML	1	3
MDS	0	2
CLL	4	3
PLL	2	2
Median no. of prior regimens (range)	4 (2-10)	4 (1-15)
Prior autologous SCT	6	8
Median cell dose infused
CD3⁺ × 10⁶/kg (range)	2.3 (.1-5.7)	2.9 (.2-11.3)
CD34⁺ × 10⁸/kg (range)	5.8 (1.7-10.4)	5.1 (1.6-7.5)

MM indicates multiple myeloma; NHL, non-Hodgkin lymphoma; AML, acute myelogenous leukemia; MDS, myelodysplastic syndrome; CLL, chronic lymphocytic leukemia; PLL, prolymphocytic leukemia.